Overview:

The Global Cell Culture Medias Market Size, is anticipated to reach USD 5,814.62 million by 2030 at 9.80% CAGR during the forecast period 2022-2030. A cell culture media can be defined as a growth media that can support the growth of cells. The media contains vitamins, amino acids, glucose, inorganic salts, serum, etc. The process may have the need for additional supplementary reagents and sera like hormones, growth factors, trace elements, lipids, and minerals. These are necessary for the growth of cell culture and has the potential to survive in their incubation environment.

The rapid growth in investment for various pharmaceutical brands, increasing congestion in the pipeline that deals with biopharmaceutical drugs in the pipeline, surge in research for personalized drugs and others can promote the Cell Culture Medias Market. But its high price can deter market growth considerably.

Cell Culture Medias Market Overview and Report Analysis by Product Type (Classical Media, Stem Cell Media, Serum-free Media), by Application (Drug Discovery and Drug Development, Toxicity Testing, Cancer Research, Genetic Engineering, Tissue Engineering & Biochemistry), by End User (Biotechnology & Pharmaceutical Companies, Research Laboratories, Academic Institutes, Pathology Lab), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030

Major Players:

Key Leading the global Cell Culture Medias Market Players include

·         Thermo Fisher Scientific (U.S.),

·         HiMedia Laboratories (India),

·         BD Biosciences (U.S.),

·         Corning Incorporated (U.S.),

·         Lonza (Switzerland),

·         Merck KGaA (Germany), and

·         GE Healthcare (U.S.) among others.

Global Cell Culture Media Market- Segmentations

For ease of understanding, the Cell Culture Medias Market has been segmented into four key dynamics: -

·         By Type : Chemically Defined Media, Serum-Free Media, Protein-Free Media, Classical Media, Custom Media, and Lysogeny Broth among others.

·         By Application: Stem Cell Research, Genetic Engineering, Tissue Engineering & Biochemistry, Toxicity Testing, Cancer Research, and Drug Discovery & Drug Development among others.

·         By End-user: Research Laboratories, Pathology Labs, Academic Institutes, and Biotechnology & Pharmaceutical Industries among others.

·         By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Cell Culture Media Market- Regional Analysis

The North American region, heading with the substantial investments transpired into R&D activities in pharmaceutical and biotech industries, dominates the global Cell Culture Medias Market Outlook. The well-developed economy of this region accounts for a key driving force behind the growth of the market that is allowing adequate funding required for R&D.  Besides, the presence of many prominent players is positively impacting the increase in the regional market.

The cell culture media market in the European region accounts for another lucrative market, globally. The increasing emphasis on R&D, especially in the biotechnology sector is a driving factor. Certainly, the resurging economy in Europe is playing a dominant role in driving the pharma sector and substantiating the growth of the market. Also, increasing funding in the rising numbers of specialty services offered by various health care providers pushes up the growth in the regional market.

The Asia Pacific cell culture media market has emerged as a profitable market, globally.  The increasing number of research labs is key factor defining the market landscape in the region. Moreover, rapidly improving economic conditions along with the proliferating pharmaceutical industries and the rapidly developing healthcare technologies in the region provide impetus to the market growth.

Global Cell Culture Media Market- Competitive Analysis

The competitive market of global Cell Culture Media appears to be highly fragmented due to the presence of several large and small players. Leverage to the high growth potential and demand in the market; these players plan to increase their production media used in the cell culture environment.

These key players also emphasis on providing the flexible packaging systems offered in multiple formats, including custom configurations to meet customized requirements. For instance, single-use bags, designed to be practical and cost-effective alternatives to rigid-walled containers, to match the specific application.  They strive to offer such containment and delivery systems that can preserve the physical, chemical, and functional characteristics of sterile fluids.

They also strive to provide a range of media, sera, and reagents, combined with disposable vessels, liquid-handling products, and advanced surfaces, that provide life science researchers with a comprehensive portfolio of products.

Industry/Innovations/Related News:

·         March 13, 2019 --– FUJIFILM Irvine Scientific, Inc. (the US), a leading global player in the optimization and manufacture of cell culture media, introduced its new product - IS Sf Insect medium. The newly developed product is a serum-free and animal component-free low hydrolysate medium which is designed meet the scalability required for the consistent growth and yields of proteins, viral vectors and viral-like particles using baculovirus expression systems (BEVS), in Sf9 and Sf21 cells.

·         March 7, 2019 --– The U.S. Department of Agriculture’s (USDA), the U.S. Department of Health & Human Services’ (HHS), Food Safety and Inspection Service (FSIS), and Food and Drug Administration (FDA), jointly announced a formal agreement to  oversee the production of human food products derived from the cells of livestock and poultry.

The formal agreement issued by the FSIS and FDA addresses the regulatory oversight of human food produced using this new technology, describing the oversight roles and responsibilities for both agencies and how the agencies will collaborate to regulate the development and entry of these products into commerce. This shared regulatory approach will ensure that cell-cultured products derived from the cell lines of livestock and poultry are produced safely and are accurately labeled.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013